nodes	percent_of_prediction	percent_of_DWPC	metapath
Tirofiban—Cardiac tamponade—Methotrexate—lymphatic system cancer	0.0591	0.0591	CcSEcCtD
Tirofiban—Haemoglobin decreased—Fludarabine—lymphatic system cancer	0.0392	0.0392	CcSEcCtD
Tirofiban—Haemorrhage intracranial—Mitoxantrone—lymphatic system cancer	0.0392	0.0392	CcSEcCtD
Tirofiban—Haemoptysis—Fludarabine—lymphatic system cancer	0.0365	0.0365	CcSEcCtD
Tirofiban—Haemoglobin decreased—Mitoxantrone—lymphatic system cancer	0.0233	0.0233	CcSEcCtD
Tirofiban—Haemoglobin—Mechlorethamine—lymphatic system cancer	0.021	0.021	CcSEcCtD
Tirofiban—Haemorrhage—Mechlorethamine—lymphatic system cancer	0.0209	0.0209	CcSEcCtD
Tirofiban—Sweating—Teniposide—lymphatic system cancer	0.0165	0.0165	CcSEcCtD
Tirofiban—Haemoglobin—Teniposide—lymphatic system cancer	0.0155	0.0155	CcSEcCtD
Tirofiban—Haemorrhage—Teniposide—lymphatic system cancer	0.0154	0.0154	CcSEcCtD
Tirofiban—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.0149	0.0149	CcSEcCtD
Tirofiban—Myocardial infarction—Fludarabine—lymphatic system cancer	0.0148	0.0148	CcSEcCtD
Tirofiban—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.0146	0.0146	CcSEcCtD
Tirofiban—Haematuria—Fludarabine—lymphatic system cancer	0.0144	0.0144	CcSEcCtD
Tirofiban—Swelling—Carmustine—lymphatic system cancer	0.0142	0.0142	CcSEcCtD
Tirofiban—Chills—Teniposide—lymphatic system cancer	0.0138	0.0138	CcSEcCtD
Tirofiban—Haemoglobin—Fludarabine—lymphatic system cancer	0.0136	0.0136	CcSEcCtD
Tirofiban—Haemorrhage—Fludarabine—lymphatic system cancer	0.0136	0.0136	CcSEcCtD
Tirofiban—Swelling—Mitoxantrone—lymphatic system cancer	0.0132	0.0132	CcSEcCtD
Tirofiban—Chills—Fludarabine—lymphatic system cancer	0.0122	0.0122	CcSEcCtD
Tirofiban—Hypertension—Teniposide—lymphatic system cancer	0.0116	0.0116	CcSEcCtD
Tirofiban—Haematemesis—Methotrexate—lymphatic system cancer	0.0115	0.0115	CcSEcCtD
Tirofiban—Oedema—Teniposide—lymphatic system cancer	0.011	0.011	CcSEcCtD
Tirofiban—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.011	0.011	CcSEcCtD
Tirofiban—Myocardial infarction—Bleomycin—lymphatic system cancer	0.0109	0.0109	CcSEcCtD
Tirofiban—Thrombocytopenia—Teniposide—lymphatic system cancer	0.0107	0.0107	CcSEcCtD
Tirofiban—Hyperhidrosis—Teniposide—lymphatic system cancer	0.0106	0.0106	CcSEcCtD
Tirofiban—Haematuria—Bleomycin—lymphatic system cancer	0.0106	0.0106	CcSEcCtD
Tirofiban—Haemoglobin—Bleomycin—lymphatic system cancer	0.00999	0.00999	CcSEcCtD
Tirofiban—Haemorrhage—Bleomycin—lymphatic system cancer	0.00994	0.00994	CcSEcCtD
Tirofiban—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00963	0.00963	CcSEcCtD
Tirofiban—Oedema—Fludarabine—lymphatic system cancer	0.00963	0.00963	CcSEcCtD
Tirofiban—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00943	0.00943	CcSEcCtD
Tirofiban—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00931	0.00931	CcSEcCtD
Tirofiban—Myocardial infarction—Vincristine—lymphatic system cancer	0.00904	0.00904	CcSEcCtD
Tirofiban—Chills—Bleomycin—lymphatic system cancer	0.00892	0.00892	CcSEcCtD
Tirofiban—Sweating—Vincristine—lymphatic system cancer	0.00885	0.00885	CcSEcCtD
Tirofiban—Nausea—Mechlorethamine—lymphatic system cancer	0.00883	0.00883	CcSEcCtD
Tirofiban—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.00881	0.00881	CcSEcCtD
Tirofiban—Haemoglobin—Carmustine—lymphatic system cancer	0.00872	0.00872	CcSEcCtD
Tirofiban—Urticaria—Teniposide—lymphatic system cancer	0.00871	0.00871	CcSEcCtD
Tirofiban—Haemorrhage—Carmustine—lymphatic system cancer	0.00868	0.00868	CcSEcCtD
Tirofiban—Body temperature increased—Teniposide—lymphatic system cancer	0.00866	0.00866	CcSEcCtD
Tirofiban—Sweating—Mitoxantrone—lymphatic system cancer	0.00861	0.00861	CcSEcCtD
Tirofiban—Haematuria—Mitoxantrone—lymphatic system cancer	0.00857	0.00857	CcSEcCtD
Tirofiban—Pain—Fludarabine—lymphatic system cancer	0.00824	0.00824	CcSEcCtD
Tirofiban—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00821	0.00821	CcSEcCtD
Tirofiban—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.00811	0.00811	CcSEcCtD
Tirofiban—Hypersensitivity—Teniposide—lymphatic system cancer	0.00807	0.00807	CcSEcCtD
Tirofiban—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.00807	0.00807	CcSEcCtD
Tirofiban—Body temperature increased—Fludarabine—lymphatic system cancer	0.00761	0.00761	CcSEcCtD
Tirofiban—Chills—Mitoxantrone—lymphatic system cancer	0.00724	0.00724	CcSEcCtD
Tirofiban—Hypersensitivity—Fludarabine—lymphatic system cancer	0.0071	0.0071	CcSEcCtD
Tirofiban—Oedema—Bleomycin—lymphatic system cancer	0.00706	0.00706	CcSEcCtD
Tirofiban—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00706	0.00706	CcSEcCtD
Tirofiban—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00691	0.00691	CcSEcCtD
Tirofiban—Headache—Teniposide—lymphatic system cancer	0.00687	0.00687	CcSEcCtD
Tirofiban—Hypertension—Carmustine—lymphatic system cancer	0.00652	0.00652	CcSEcCtD
Tirofiban—Nausea—Teniposide—lymphatic system cancer	0.00651	0.00651	CcSEcCtD
Tirofiban—Hypertension—Vincristine—lymphatic system cancer	0.00622	0.00622	CcSEcCtD
Tirofiban—Oedema—Carmustine—lymphatic system cancer	0.00616	0.00616	CcSEcCtD
Tirofiban—Hypertension—Mitoxantrone—lymphatic system cancer	0.00606	0.00606	CcSEcCtD
Tirofiban—Pain—Bleomycin—lymphatic system cancer	0.00604	0.00604	CcSEcCtD
Tirofiban—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00604	0.00604	CcSEcCtD
Tirofiban—Headache—Fludarabine—lymphatic system cancer	0.00603	0.00603	CcSEcCtD
Tirofiban—Oedema—Vincristine—lymphatic system cancer	0.00588	0.00588	CcSEcCtD
Tirofiban—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00588	0.00588	CcSEcCtD
Tirofiban—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00576	0.00576	CcSEcCtD
Tirofiban—Oedema—Mitoxantrone—lymphatic system cancer	0.00573	0.00573	CcSEcCtD
Tirofiban—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00573	0.00573	CcSEcCtD
Tirofiban—Nausea—Fludarabine—lymphatic system cancer	0.00572	0.00572	CcSEcCtD
Tirofiban—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00569	0.00569	CcSEcCtD
Tirofiban—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00561	0.00561	CcSEcCtD
Tirofiban—Urticaria—Bleomycin—lymphatic system cancer	0.00561	0.00561	CcSEcCtD
Tirofiban—Body temperature increased—Bleomycin—lymphatic system cancer	0.00558	0.00558	CcSEcCtD
Tirofiban—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00554	0.00554	CcSEcCtD
Tirofiban—Pain—Carmustine—lymphatic system cancer	0.00527	0.00527	CcSEcCtD
Tirofiban—Hypersensitivity—Bleomycin—lymphatic system cancer	0.0052	0.0052	CcSEcCtD
Tirofiban—Pain—Vincristine—lymphatic system cancer	0.00503	0.00503	CcSEcCtD
Tirofiban—Pain—Mitoxantrone—lymphatic system cancer	0.0049	0.0049	CcSEcCtD
Tirofiban—Body temperature increased—Carmustine—lymphatic system cancer	0.00487	0.00487	CcSEcCtD
Tirofiban—Body temperature increased—Vincristine—lymphatic system cancer	0.00465	0.00465	CcSEcCtD
Tirofiban—Urticaria—Mitoxantrone—lymphatic system cancer	0.00455	0.00455	CcSEcCtD
Tirofiban—Hypersensitivity—Carmustine—lymphatic system cancer	0.00454	0.00454	CcSEcCtD
Tirofiban—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00453	0.00453	CcSEcCtD
Tirofiban—Hypersensitivity—Vincristine—lymphatic system cancer	0.00434	0.00434	CcSEcCtD
Tirofiban—Sweating—Methotrexate—lymphatic system cancer	0.00429	0.00429	CcSEcCtD
Tirofiban—Haematuria—Methotrexate—lymphatic system cancer	0.00427	0.00427	CcSEcCtD
Tirofiban—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00422	0.00422	CcSEcCtD
Tirofiban—Nausea—Bleomycin—lymphatic system cancer	0.00419	0.00419	CcSEcCtD
Tirofiban—Dizziness—Carmustine—lymphatic system cancer	0.00408	0.00408	CcSEcCtD
Tirofiban—Haemoglobin—Methotrexate—lymphatic system cancer	0.00404	0.00404	CcSEcCtD
Tirofiban—Haemorrhage—Methotrexate—lymphatic system cancer	0.00402	0.00402	CcSEcCtD
Tirofiban—Dizziness—Vincristine—lymphatic system cancer	0.00389	0.00389	CcSEcCtD
Tirofiban—Headache—Carmustine—lymphatic system cancer	0.00386	0.00386	CcSEcCtD
Tirofiban—Headache—Vincristine—lymphatic system cancer	0.00369	0.00369	CcSEcCtD
Tirofiban—Nausea—Carmustine—lymphatic system cancer	0.00366	0.00366	CcSEcCtD
Tirofiban—Chills—Methotrexate—lymphatic system cancer	0.00361	0.00361	CcSEcCtD
Tirofiban—Headache—Mitoxantrone—lymphatic system cancer	0.00359	0.00359	CcSEcCtD
Tirofiban—Nausea—Vincristine—lymphatic system cancer	0.0035	0.0035	CcSEcCtD
Tirofiban—Nausea—Mitoxantrone—lymphatic system cancer	0.0034	0.0034	CcSEcCtD
Tirofiban—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00286	0.00286	CcSEcCtD
Tirofiban—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Tirofiban—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00276	0.00276	CcSEcCtD
Tirofiban—Pain—Methotrexate—lymphatic system cancer	0.00244	0.00244	CcSEcCtD
Tirofiban—Urticaria—Methotrexate—lymphatic system cancer	0.00227	0.00227	CcSEcCtD
Tirofiban—Body temperature increased—Methotrexate—lymphatic system cancer	0.00226	0.00226	CcSEcCtD
Tirofiban—Hypersensitivity—Methotrexate—lymphatic system cancer	0.0021	0.0021	CcSEcCtD
Tirofiban—Dizziness—Methotrexate—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Tirofiban—Headache—Methotrexate—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Tirofiban—Nausea—Methotrexate—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
